Replimune Group, Inc. (REPL)

Replimune Group Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Selling, General & Admin	60.72	60.72	50.97	39.18	23.55	17.44
Research & Development	172.13	172.13	123.19	75.97	53.6	35.68
Operating Expenses	232.85	232.85	174.17	115.14	77.15	53.11
Operating Income	-232.85	-232.85	-174.17	-115.14	-77.15	-53.11
Interest Expense	-6.66	-6.66	-4.16	-2.22	-3.06	-1.92
Interest & Investment Income	23.36	23.36	10.01	0.39	0.92	2.42
Currency Exchange Gain (Loss)	0.77	0.77	-5.68	-1.1	-0.7	-0.02
Other Non Operating Income (Expenses)	-	-	-	0.04	0.04	-
EBT Excluding Unusual Items	-215.39	-215.39	-174	-118.04	-79.96	-52.63
Other Unusual Items	-	-	-	-	-0.91	-
Pretax Income	-215.39	-215.39	-174	-118.04	-80.87	-52.63
Income Tax Expense	0.41	0.41	0.29	-	-	-
Net Income	-215.79	-215.79	-174.28	-118.04	-80.87	-52.63
Net Income to Common	-215.79	-215.79	-174.28	-118.04	-80.87	-52.63
Shares Outstanding (Basic)	67	67	58	52	46	34
Shares Outstanding (Diluted)	67	67	58	52	46	34
Shares Change (YoY)	14.36%	14.36%	11.49%	12.89%	34.99%	47.69%
EPS (Basic)	-3.24	-3.24	-2.99	-2.26	-1.75	-1.54
EPS (Diluted)	-3.24	-3.24	-2.99	-2.26	-1.75	-1.54
Free Cash Flow	-191.13	-191.13	-130.32	-84.52	-63.78	-67.09
Free Cash Flow Per Share	-2.87	-2.87	-2.24	-1.62	-1.38	-1.96
EBITDA	-230.2	-230.2	-171.72	-113	-75.44	-52.58
D&A For EBITDA	2.66	2.66	2.45	2.15	1.71	0.53
EBIT	-232.85	-232.85	-174.17	-115.14	-77.15	-53.11

Source: S&P Capital IQ. Standard template.